Statewide Optimization of Lung Cancer Screening Utilizing the QUILS™ System in Nevada and Mississippi: State-Based Initiative Component

Part of paid clinical trials in Greenville, Mississippi.

Sponsor
Timothy Mullett
Study ID
NCT07682597
Status
Recruiting

Conditions

  • Lung Cancer Screening

Eligibility Criteria

Sex
ALL
Age
18 Years - 100 Years
Healthy Volunteers
Not accepted

Interventions

  • QUILS SBI Intervention — BEHAVIORAL
    Participants implement the QUILS™ SBI intervention over 4 years consisting of the following steps: 1) Hire and establish connections with both groups, work with the MSLCRT and NLCC during year 1; 2) Participate in annual meetings hosted by MSCLRT and NLCC during years 1-4; 3) Attend State Team Assessment Feedback Sessions during years 2-4; 4) Attend Coalition Assessment Feedback Sessions during years 2-4; 5) Prioritize objectives, identify areas to support, implementation of state-based initiative, and receive coaching/support during years 2 and 3; 6) Receive coaching and technical assistance to implement priority areas during years 1-4; 7) Participate in sustainability planning during year 4.

Study Details

This clinical trial studies whether a Quality Implementation of Lung Cancer Screening (QUILS™) System state-based initiative (SBI) intervention works to improve the statewide capacity for implementing and sustaining lung cancer screening in Mississippi (MS) and Nevada (NV). The QUILS™ Group is focused on fair and high-quality implementation of lung cancer screening among eligible individuals to reduce lung cancer-related death in underserved communities. Previous research had success with implementing interventions in Kentucky which has lead to significant increases in lung cancer screening rates and a rapid decline in late-stage lung cancer diagnoses within the state. The goal is to offer the opportunity to replicate this work in states which are eager to address suboptimal screening rates, high lung cancer-related death, and significant health equity concerns. The QUILS™ SBI intervention involves translating the success of the initial work in Kentucky to impact lung cancer screening implementation and lung cancer outcomes in MS and NV through close collaboration with state-based partners. The QUILS™ SBI intervention may be an effective way to improve the statewide capacity for implementing and sustaining lung cancer screening in MS and NV.

Key Dates

Start date
Mar 1, 2026
Status verified
Jun 2026
Primary completion
Jul 1, 2028
Completion
Jul 1, 2029

Study Design

Enrollment
200 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING

Arms

  • Experimental: Health Services Research (SBI Intervention)
    Participants implement the QUILS™ SBI intervention over 4 years consisting of the following steps: 1) Hire and establish connections with both groups, work with the MSLCRT and NLCC during year 1; 2) Participate in annual meetings hosted by MSCLRT and NLCC during years 1-4; 3) Attend State Team Assessment Feedback Sessions during years 2-4; 4) Attend Coalition Assessment Feedback Sessions during years 2-4; 5) Prioritize objectives, identify areas to support, implementation of state-based initiative, and receive coaching/support during years 2 and 3; 6) Receive coaching and technical assistance to implement priority areas during years 1-4; 7) Participate in sustainability planning during year 4.

Primary Outcome Measure

Change in Statewide Capacity Assessment Scores for Lung Cancer Screening Implementation and Sustainability Capacity [ Time Frame: Up to 3 Years ]

Central Contacts

Locations (13)

FacilityCityStateZIPSite coordinators
Delta Health SystemGreenvilleMississippi38703
Joseph Alexander
859-323-0892
Greenwood Leflore HospitalGreenwoodMississippi38930
Joseph Alexander
8593230892
Memorial Hospital GulfportGulfportMississippi39501
Joseph Alexander
8593230892
Hattiesburg ClinicHattiesburgMississippi39401
Joseph Alexander
859-323-0892
University of Mississippi Medical CenterJacksonMississippi39216
Joseph Alexander
8593230892
Baptist Memorial HospitalNew AlbanyMississippi38652
Joseph Alexander
8593230892
North Mississippi Health ServicesTupeloMississippi38801
Joseph Alexander
8593230892
Mt. Grant General HospitalHawthorneNevada89415
Jospeh Alexander
8593230892
Desert View HospitalPahrumpNevada89048
Joseph Alexander
8593230892
Renown Regional Medical CenterRenoNevada89502
Joseph Alexander
8593230892
Sierra Medical CenterRenoNevada89511
Joseph Alexander
8593230892
Sunrise HealthWinchesterNevada89109
Joseph Alexander
8593230892
Humboldt General HospitalWinnemuccaNevada89445
Joseph Alexander
8593230892

Find similar trials in Greenville, MS

Related Studies